Compound Detail
CHEMBL1328
PENTAGASTRIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Basic Information
| ChEMBL ID | CHEMBL1328 |
| Name | PENTAGASTRIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NEYNJQRKHLUJRU-DZUOILHNSA-N |
5
Targets
17
Activities
4
Assay Types
1
PK Parameters
20
Publications
8
Known Names
Molecular Properties
767.9
MW (Da)
1.52
ALogP
9
HBA
8
HBD
250.9
PSA (Ų)
0.08
QED
2
Ro5 Violations
20
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1974 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
ATC Classification
V04CG04
pentagastrin
Level 1: VARIOUS
Level 2: DIAGNOSTIC AGENTS
Activity Summary
IC50 10 meas. best 9.1
Ki 4 meas. best 7.84
EC50 2 meas. best 9.37
Kd 1 meas. best 8.01
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Gastrin/cholecystokinin type B receptor CHEMBL3508 | EC50 | 9.37 | 9.37 | 0.4 | 1 |
| Gastrin/cholecystokinin type B receptor CHEMBL2854 | IC50 | 9.1 | 9.1 | 0.8 | 3 |
| Gastrin/cholecystokinin type B receptor CHEMBL298 | IC50 | 9.0 | 7.11 | 1.0 | 2 |
| Gastrin/cholecystokinin type B receptor CHEMBL298 | EC50 | 8.55 | 8.55 | 2.8 | 1 |
| Gastrin/cholecystokinin type B receptor CHEMBL3508 | IC50 | 8.17 | 8.17 | 6.8 | 1 |
| Mus musculus CHEMBL375 | Kd | 8.01 | 8.01 | 9.8 | 1 |
| Gastrin/cholecystokinin type B receptor CHEMBL298 | Ki | 7.84 | 7.5933 | 14.5 | 3 |
| Cholecystokinin receptor type A CHEMBL2871 | IC50 | 6.22 | 6.105 | 600.0 | 4 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Ke | 1.4 | nM | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| 33226806 | 10.1021/acs.jmedchem.0c01233 | Gastrin/cholecystokinin type B receptor | 3 |
| 1732532 | 10.1021/jm00079a003 | Gastrin/cholecystokinin type B receptor | 3 |
| 11312913 | 10.1021/jm0010668 | Mus musculus | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| - | 10.1016/0960-894X(95)00435-V | Gastrin/cholecystokinin type B receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 1732532 | 10.1021/jm00079a003 | Cholecystokinin receptor type A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Mu-type opioid receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 1671419 | 10.1021/jm00105a062 | Cholecystokinin receptor type A | 1 |
| 7684452 | 10.1021/jm00057a005 | Unchecked | 1 |
| 7684452 | 10.1021/jm00057a005 | Gastrin/cholecystokinin type B receptor | 1 |
Data from ChEMBL 36 via Core Engine